<DOC>
	<DOCNO>NCT02367547</DOCNO>
	<brief_summary>This pilot study compare three photosensitisers , hexylaminolevulinate ( HAL ) aminolevulinic acid nano emulsion ( BF-200 ALA ) methylaminolevulinate ( MAL ) photodynamic therapy superficially grow basal cell carcinoma . Study conduct use randomised prospective double blind compare design . Fluorescence measure A.U . ( Arbitrary Unit ) standardise set-up exposure . Efficacy assess clinically , histologically hyperspectral image system 3 month , 12 month 5 year .</brief_summary>
	<brief_title>Superficial Basal Cell Cancer 's Photodynamic Therapy : Comparing Three Photosensitises : HAL BF-200 ALA Versus MAL</brief_title>
	<detailed_description>Study recruit volunteer patient , refer department dermatology allergology , Päijät-Häme Central Hospital , Lahti , 99 clinically assess superficial basal cell carcinoma body area , face scalp . Diagnoses confirm histologically punch biopsy hyperspectral image take biopsy . The lesion randomise three group : intervention HAL BF-200 ALA comparator MAL . Photodynamic therapy give standard procedure . Fluorescence measure A.U . ( Arbitrary Unit ) standardise set-up , Wood 's light , digital camera yellow lens , exposure . Pain measured VAS-scale , exposure . Efficacy assess clinically , histologically hyperspectral image system 3 month , 12 month 5 year .</detailed_description>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Dermatitis , Phototoxic</mesh_term>
	<mesh_term>Neoplasms , Basal Cell</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>superficial basal cell carcinoma body area lesion accept need 10 cm apart pigment , morpheaform , infiltrative nodular basal cell carcinoma lesion face scalp area pregnancy breast feed allergy photosensitizer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>